Orion Integrated Biosciences
Orion Integrated Biosciences, founded in 2005 and headquartered in Manhattan, KS, is a biodefense company specializing in the identification of microbes using genomic signatures. The company leverages expertise in bioinformatics, microbiology, and artificial intelligence to develop next-generation pathogen detection and characterization platforms, vaccines, and antimicrobials. They focus on addressing health, trade, and security challenges by monitoring and tracking known and unknown biothreats. Orion Integrated Biosciences has received support from various government agencies including DHS-S&T-OUP, DHS-CBP, DoD, DTRA, USDA, NIH, and the EU, and collaborates with national laboratories and universities. Willy A. Valdivia is the founder and CEO, recognized as a successful Latin-American bio-entrepreneur.
Orion Integrated Biosciences
Orion Integrated Biosciences, founded in 2005 and headquartered in Manhattan, KS, is a biodefense company specializing in the identification of microbes using genomic signatures. The company leverages expertise in bioinformatics, microbiology, and artificial intelligence to develop next-generation pathogen detection and characterization platforms, vaccines, and antimicrobials. They focus on addressing health, trade, and security challenges by monitoring and tracking known and unknown biothreats. Orion Integrated Biosciences has received support from various government agencies including DHS-S&T-OUP, DHS-CBP, DoD, DTRA, USDA, NIH, and the EU, and collaborates with national laboratories and universities. Willy A. Valdivia is the founder and CEO, recognized as a successful Latin-American bio-entrepreneur.